PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Université Paris-Saclay, Inserm, CEA, Center for Immunology of Viral, Auto-immune, Hematological and Bacterial diseases (IMVA-HB/IDMIT), Fontenay-aux-Roses & Le Kremlin-Bicêtre, Paris, France.\', \'Departments of Medical Microbiology of the Amsterdam UMC, University of Amsterdam, Amsterdam Institute for Infection and Immunity, Amsterdam, The Netherlands.\', \'Université de Paris, INSERM, IAME, Paris, France.\', \'Department of Pathology, University of Texas Medical Branch at Galveston, Galveston, TX, USA.\', \'Galveston National Laboratory, Galveston, TX, USA.\', \'Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.\', \'Life and Soft, Le Plessis-Robinson, France.\', \'Graduate School of Biomedical Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA.\', \'Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA, USA.\', \'Department of Microbiology, University of Texas Medical Branch at Galveston, Galveston, TX, USA.\', \'Duke Human Vaccine Institute & Department of Surgery, Durham, NC, USA.\', \'Nexelis, Laval, Québec, Canada.\', \'Internal Medicine of the Amsterdam UMC, University of Amsterdam, Amsterdam Institute for Infection and Immunity, Amsterdam, The Netherlands.\', \'Department of Medicine, Division of Infectious Diseases, Icahn School of Medicine at Mount Sinai, New York, NY, USA.\', \'The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.\', \'Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.\', \'University of Maryland School of Medicine, Department of Microbiology and Immunology and Center for Vaccine Development and Global Health (CVD), Baltimore, MD, USA.\', \'Molecular Genetics of RNA Viruses, Department of Virology, Institut Pasteur, CNRS UMR 3569, Université de Paris, Paris, France.\', \'National Reference Center for Respiratory Viruses, Institut Pasteur, Paris, France.\', \'Departments of Medical Microbiology of the Amsterdam UMC, University of Amsterdam, Amsterdam Institute for Infection and Immunity, Amsterdam, The Netherlands. r.w.sanders@amsterdamumc.nl.\', \'Department of Microbiology and Immunology, Weill Medical College of Cornell University, New York, NY, USA. r.w.sanders@amsterdamumc.nl.\', \'Departments of Medical Microbiology of the Amsterdam UMC, University of Amsterdam, Amsterdam Institute for Infection and Immunity, Amsterdam, The Netherlands. m.j.vangils@amsterdamumc.nl.\', \'Université Paris-Saclay, Inserm, CEA, Center for Immunology of Viral, Auto-immune, Hematological and Bacterial diseases (IMVA-HB/IDMIT), Fontenay-aux-Roses & Le Kremlin-Bicêtre, Paris, France. roger.le-grand@cea.fr.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1038/s41467-021-26354-0
?:doi
?:hasPublicationType
?:journal
  • Nature communications
is ?:pmid of
?:pmid
?:pmid
  • 34671037
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 6.582
?:rankingScore_hIndex
  • 198
is ?:relation_isRelatedTo_publication of
?:title
  • COVA1-18 neutralizing antibody protects against SARS-CoV-2 in three preclinical models.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all